Discovery of a peripheral 5HT2A antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis.
Pagire HS, Pagire SH, Jeong BK, Choi WI, Oh CJ, Lim CW, Kim M, Yoon J, Kim SS, Bae MA, Jeon JH, Song S, Lee HJ, Lee EY, Goughnour PC, Kim D, Lee IK, Loomba R, Kim H, Ahn JH.
Pagire HS, et al. Among authors: lee ey, lee hj, lee ik.
Nat Commun. 2024 Jan 20;15(1):645. doi: 10.1038/s41467-024-44874-3.
Nat Commun. 2024.
PMID: 38245505
Free PMC article.